Century Therapeutics, Inc. (IPSC)
NASDAQ · Healthcare
Century Therapeutics, Inc. Operating Income 2022–2025
Century Therapeutics, Inc. annual/quarterly operating income history and growth rate from 2022 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Century Therapeutics, Inc. operating income for the quarter ending March 31, 2025 was 74.2 M, a 336.92% decrease year-over-year.
- Century Therapeutics, Inc. operating income for the twelve months ending March 31, 2025 was -26.7 M, a 80.17% decrease year-over-year.
- Century Therapeutics, Inc. annual operating income for 2025 was -17.3 M, a 87.50% decrease from 2024.
- Century Therapeutics, Inc. annual operating income for 2024 was -138.1 M, a 5.74% decrease from 2023.
- Century Therapeutics, Inc. annual operating income for 2023 was -146.5 M, a 9.50% increase from 2022.
- Century Therapeutics, Inc. annual operating income for 2022 was -133.8 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Century Therapeutics, Inc. Operating Income — FAQ
Century Therapeutics, Inc. (IPSC) operating income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Century Therapeutics, Inc.'s operating income?
Century Therapeutics, Inc. (IPSC) reported operating income of -$17M for fiscal 2025.
Where can I see IPSC's operating income history?
The chart and table above show Century Therapeutics, Inc.'s operating income by year and by quarter, including the growth rate.